Hypertrophic Scars Therapeutics Pipeline- Technological Advancements Enhancing the Growth: P&S Market Research

NEW YORK, March 29, 2018 -- According to a new research report titled “Hypertrophic Scars Therapeutics Pipeline Analysis, 2017” published by P&S Market Research, Hypertrophic scars currently exhibits a growing pipeline with nine drug candidates.

Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/hypertrophic-scars-therapeutics-pipeline-analysis/report-sample

Body cells known as myofibroblasts produce excessive collagen during healing process which can be deposited as a bump and later changes to a hypertrophic scar. The study analyzed that the hypertrophic scars therapeutics pipeline comprises approximately nine drug candidates in different stages of development.

Majority of the pipeline drug candidates are being developed to be administered by the topical route. SCX-001 cream has demonstrated anti-scarring effects in two in-vivo Pre-clinical dermal models. SCX-001 cream’s safety as a topical agent has also been confirmed in non-clinical Investigational New Drug (IND) in-vitro and in-vivo studies.

Browse Full Report with detailed TOC on “Hypertrophic Scars Therapeutics Pipeline” at: https://www.psmarketresearch.com/market-analysis/hypertrophic-scars-therapeutics-pipeline-analysis

Technological advancements have been strengthening the development of pipeline drugs for the treatment of hypertrophic scars. For instance, The RNA interference (RNAi) technology, was used in the development of OLX101 by OliX Pharmaceuticals, Inc.

Some of the players developing drugs for the treatment of hypertrophic scars include RXi Pharmaceuticals Corporation, Sirnaomics, Inc., ScarX Therapeutics, Inc., and Scarless Laboratories, Inc.

More Reports Published by P&S Market Research

T-Cell Immunotherapy Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/t-cell-immunotherapy-pipeline-analysis

Beta-Secretase Inhibitors Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/beta-secretase-inhibitors-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook